These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2500759)

  • 1. Incompatible blood transfusions in liver transplant patients with significant red cell alloantibodies.
    Ramsey G; Cornell FW; Hahn LF; Fonzi F; Starzl TE
    Transplant Proc; 1989 Jun; 21(3):3531. PubMed ID: 2500759
    [No Abstract]   [Full Text] [Related]  

  • 2. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.
    Zaidi U; Borhany M; Ansari S; Parveen S; Boota S; Shamim I; Zahid D; Shamsi T
    Transfus Med; 2015 Apr; 25(2):106-10. PubMed ID: 25870030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blood transfusion in surgery. Immunological principles].
    Schönitzer D
    Infusionsther Klin Ernahr; 1982 Dec; 9(6):273-8. PubMed ID: 6819231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Cox JV; Steane E; Cunningham G; Frenkel EP
    Arch Intern Med; 1988 Nov; 148(11):2485-9. PubMed ID: 3142382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood transfusion complications due to Kell factor incompatibility of the transfused blood].
    Skachilova NN; Umnova MA; Morozova AD; Shakhsuvarov VD; Beliaev VV
    Probl Gematol Pereliv Krovi; 1982 Dec; 27(12):16-20. PubMed ID: 7156084
    [No Abstract]   [Full Text] [Related]  

  • 6. Red cell alloimmunization in sickle cell disease.
    Davies SC; McWilliam AC; Hewitt PE; Devenish A; Brozovic M
    Br J Haematol; 1986 Jun; 63(2):241-5. PubMed ID: 3087406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibody anti-Kell (K1). An analysis of two post-transfusion haemolytic reactions (author's transl)].
    Fischer O; Snopková O
    Cas Lek Cesk; 1981 Jan; 120(3-4):96-9. PubMed ID: 7214435
    [No Abstract]   [Full Text] [Related]  

  • 8. Alloimmunization to both Rh and Kell system antigens (anti-C and anti-K) in a young thalassemic patient.
    Arora S; Dhawan HK; Sachdev S; Patidar G; Sharma RR; Marwaha N; Trehan A; Marwaha RK
    Indian J Pathol Microbiol; 2010; 53(4):889-90. PubMed ID: 21045471
    [No Abstract]   [Full Text] [Related]  

  • 9. Interdonor incompatibility due to anti-Kell antibody undetectable by automated antibody screening.
    West NC; Jenkins JA; Johnston BR; Modi N
    Vox Sang; 1986; 50(3):174-6. PubMed ID: 3716289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of the BG 15 autoanalyzer for automatic recording and determination of ABO, Rhesus and Kell blood groups].
    Girard M; Michaud C
    Rev Fr Transfus Immunohematol; 1979 Jun; 22(3):265-74. PubMed ID: 115076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do you think that the cross match with donor red cells can be omitted when the serum of a patient has been tested for the presence of red cell alloantibodies with a cell panel?
    Vox Sang; 1982; 43(3):151-68. PubMed ID: 6815895
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunological blood transfusion safety and selection of red blood cells issued from hospital blood banks].
    Py JY
    Transfus Clin Biol; 2010 Dec; 17(5-6):334-40. PubMed ID: 21050787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody screening & identification in the general patient population at a tertiary care hospital in New Delhi, India.
    Makroo RN; Bhatia A; Hegde V; Chowdhry M; Thakur UK; Rosamma NL
    Indian J Med Res; 2014 Sep; 140(3):401-5. PubMed ID: 25366208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terminology for red cell surface antigens. ISBT Working Party Oslo Report. International Society of Blood Transfusion.
    Daniels GL; Anstee DJ; Cartron JP; Dahr W; Garratty G; Henry S; Jørgensen J; Judd WJ; Kornstad L; Levene C; Lomas-Francis C; Lubenko A; Moulds JJ; Moulds JM; Moulds M; Overbeeke M; Reid ME; Rouger P; Scott M; Seidl S; Sistonen P; Tani Y; Wendel S; Zelinski T
    Vox Sang; 1999; 77(1):52-7. PubMed ID: 10474091
    [No Abstract]   [Full Text] [Related]  

  • 15. Red cell alloantibodies in thalassemia major. Results of an Italian cooperative study.
    Sirchia G; Zanella A; Parravicini A; Morelati F; Rebulla P; Masera G
    Transfusion; 1985; 25(2):110-2. PubMed ID: 3920790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy outcome in mothers who develop Kell antibodies.
    Farr V; Gray E
    Scott Med J; 1988 Aug; 33(4):300-3. PubMed ID: 3055288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloimmunisation in thalassaemics: a comparison between recipients of usual matched and partial better matched blood. An evaluation at a tertiary care centre in India.
    Pujani M; Pahuja S; Dhingra B; Chandra J; Jain M
    Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s100-4. PubMed ID: 23399366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-K12 in the serum of two brothers: inheritance of the K:-12 phenotype.
    Beattie KM; Heinz B; Korol S; Oyen R; Marsh WL
    Rev Fr Transfus Immunohematol; 1982 Dec; 25(6):611-8. PubMed ID: 7170567
    [No Abstract]   [Full Text] [Related]  

  • 19. Kell sensitization in pregnancy.
    Bowman JM
    Am J Obstet Gynecol; 1986 Oct; 155(4):912-4. PubMed ID: 3766648
    [No Abstract]   [Full Text] [Related]  

  • 20. Chorionic biopsy in management of severe Kell alloimmunization.
    Rodesch F; Lambermont M; Donner C; Simon P; Romasco F; Schwers J; Wybran J
    Am J Obstet Gynecol; 1987 Jan; 156(1):124-5. PubMed ID: 3799745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.